Press Release: European Medicines Agency updates on pandemic influenza

Author (Corporate)
Series Title
Series Details EMEA/37589/ 2010 (22.1.10)
Publication Date 22/01/2010
Content Type

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in January 2010, recommended the granting of a conditional marketing authorisation for a fourth pandemic vaccine, Arepanrix from GlaxoSmithKline Biologicals.
Source Link http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/01/news_detail_000984.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Public statement on Arepanrix: Withdrawal of the marketing authorisation in the European Union http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/01/news_detail_001183.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1
Subject Categories
Countries / Regions